PURPOSE: To investigate the effectiveness of a polydisulfide-based biodegradable macromolecular contrast agent, (Gd-DTPA)-cystamine copolymers (GDCC), in assessing the efficacy of indocyanine green-enhanced photothermal cancer therapy using dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI). MATERIALS AND METHODS: Breast cancer xenografts in mice were injected with indocyanine green and irradiated with a laser. The efficacy was assessed using DCE-MRI with GDCC of 40 kDa (GDCC-40) at 4 hours and 7 days after the treatment. The uptake of GDCC-40 by the tumors was fit to a two-compartment model to obtain tumor vascular parameters, including fractional plasma volume (f(PV)), endothelium transfer coefficient (K(PS)), and permeability surface area product (PS). RESULTS: GDCC-40 resulted in similar tumor vascular parameters at three doses, with larger standard deviations at lower doses. The values of f(PV), K(PS), and PS of the treated tumors were smaller (P < 0.05) than those of untreated tumors at 4 hours after the treatment and recovered to pretreatment values (P > 0.05) at 7 days after the treatment. CONCLUSION: DCE-MRI with GDCC-40 is effective for assessing tumor early response to dye-enhanced photothermal therapy and detecting tumor relapse after the treatment. GDCC-40 has a potential to noninvasively monitor anticancer therapies with DCE-MRI. (c) 2009 Wiley-Liss, Inc.
PURPOSE: To investigate the effectiveness of a polydisulfide-based biodegradable macromolecular contrast agent, (Gd-DTPA)-cystamine copolymers (GDCC), in assessing the efficacy of indocyanine green-enhanced photothermal cancer therapy using dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI). MATERIALS AND METHODS:Breast cancer xenografts in mice were injected with indocyanine green and irradiated with a laser. The efficacy was assessed using DCE-MRI with GDCC of 40 kDa (GDCC-40) at 4 hours and 7 days after the treatment. The uptake of GDCC-40 by the tumors was fit to a two-compartment model to obtain tumor vascular parameters, including fractional plasma volume (f(PV)), endothelium transfer coefficient (K(PS)), and permeability surface area product (PS). RESULTS:GDCC-40 resulted in similar tumor vascular parameters at three doses, with larger standard deviations at lower doses. The values of f(PV), K(PS), and PS of the treated tumors were smaller (P < 0.05) than those of untreated tumors at 4 hours after the treatment and recovered to pretreatment values (P > 0.05) at 7 days after the treatment. CONCLUSION:DCE-MRI with GDCC-40 is effective for assessing tumor early response to dye-enhanced photothermal therapy and detecting tumor relapse after the treatment. GDCC-40 has a potential to noninvasively monitor anticancer therapies with DCE-MRI. (c) 2009 Wiley-Liss, Inc.
Authors: Quido G de Lussanet; Sander Langereis; Regina G H Beets-Tan; Marcel H P van Genderen; Arjan W Griffioen; Jos M A van Engelshoven; Walter H Backes Journal: Radiology Date: 2005-02-24 Impact factor: 11.105
Authors: Yuda Zong; Xinghe Wang; K Craig Goodrich; Aaron M Mohs; Dennis L Parker; Zheng-Rong Lu Journal: Magn Reson Med Date: 2005-04 Impact factor: 4.668
Authors: T H Helbich; A Gossman; P A Mareski; B Radüchel; T P Roberts; D M Shames; M Mühler; K Turetschek; R C Brasch Journal: J Magn Reson Imaging Date: 2000-06 Impact factor: 4.813
Authors: Martin R Prince; Honglei Zhang; Michael Morris; Jennifer L MacGregor; Marc E Grossman; Jeffrey Silberzweig; Robert L DeLapaz; Henry J Lee; Cynthia M Magro; Anthony M Valeri Journal: Radiology Date: 2008-09 Impact factor: 11.105
Authors: Aaron M Mohs; Xinghe Wang; K Craig Goodrich; Yuda Zong; Dennis L Parker; Zheng-Rong Lu Journal: Bioconjug Chem Date: 2004 Nov-Dec Impact factor: 4.774